Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 18];7(2):s140. Available from: https://skin.dermsquared.com/skin/article/view/2029